Breakthrough research shows cannabis compounds like THC can clear toxic proteins linked to Alzheimer's disease from brain cells.

Researchers at the Salk Institute and Scripps Research Institute have identified compelling evidence that tetrahydrocannabinol (THC) and other cannabinoids can target the root causes of Alzheimer's disease. Laboratory tests on human nerve cells revealed that these compounds help remove amyloid-beta, a toxic protein that forms plaques and triggers damaging brain inflammation. By activating the body’s natural endocannabinoid system, these substances not only promoted the clearance of these harmful proteins but also inhibited the enzymes responsible for plaque production, effectively slowing the cellular damage associated with the disease.

While these findings highlight a significant neuroprotective potential for combined THC and CBD therapies, experts emphasize that the research is still in preliminary stages. Most successes have occurred within controlled laboratory environments and animal models, and rigorous human clinical trials are required to determine if these results translate to real-world medical benefits. Currently, there is no evidence that cannabis can cure or reverse dementia, but this exploratory work provides a vital roadmap for developing future treatments aimed at protecting the brain from inflammatory decay.

source: Salk Institute for Biological Studies. Cannabinoids remove plaque-forming Alzheimer's proteins from nerve cells. Nature: Aging and Mechanisms of Disease.